Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-10-15

Clinical Trial Update: The TRIMAXX Coronary Stent Trial [Phase 1]

View source ↗

Summary

Abbott Medical Devices reports that the Phase 1 TRIMAXX coronary stent trial in coronary artery disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRIMAXX Coronary Stent

Snippet

Sponsor: Abbott Medical Devices | Conditions: Coronary Artery Disease | Phase 1 | Status: COMPLETED